A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea

Military Medicine

Volumn 177, Issue 4, 2012, Pages 456-459

  Armbruster, Steven ^a   Goldkind, Lawrence ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE; VANCOMYCIN;

ARTICLE; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; CROSS INFECTION; DIARRHEA; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MILITARY MEDICINE; MORTALITY; OUTPATIENT; PSEUDOMEMBRANOUS COLITIS; PUBLIC HOSPITAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VETERAN;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS, MILITARY; HUMANS; INCIDENCE; INPATIENTS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; METRONIDAZOLE; MIDDLE AGED; MILITARY MEDICINE; OUTPATIENTS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VANCOMYCIN; VETERANS;

EID: 84860612214     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-11-00389     Document Type: Review

References (18)

1. Salkind AR: Clostridium difficile: an update for the primary care clinician. South Med J 2010; 103: 896-900.
2. Barbut F, Corthier G, Charpak Y, et al: Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med 1996; 156: 1449-54.
3. McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
4. Redelings MD, Sorvillo F, Mascola L: Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13: 1417-9.
5. Kyne L, Hamel MB, Polavaram R, Kelly CP: Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34: 346-53.
6. Cohen SH, Gerding DN, Johnson S, et al: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
7. Pepin J, Valiquette L, Alary ME, et al: Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171: 466-72.
8. Hessen MT: In the clinic: Clostridium difficile infection. Ann Intern Med 2010; 153: ITC41-15.
9. Dubberke ER: The A, B, BI, and Cs of Clostridium difficile. Clin Infect Dis 2009; 49: 1148-52.
10. Leffler DA, Lamont JT: Treatment of Clostridium difficile-associated disease. Gastroenterology 2009; 136: 1899-912.
11. Howell MD, Novack V, Grgurich P, et al: Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010; 170: 784-90.
12. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA: Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010; 170: 772-8.
13. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45: 302-7.
14. Surawicz CM: Reining in recurrent Clostridium difficile infection-who's at risk? Gastroenterology 2009; 136: 1152-4.
15. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY: National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009; 37: 263-70.
16. Loo VG, Bourgault AM, Poirier L, et al: Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011; 365: 1693-703.
17. Bengualid V, Umesh KC, Alapati J, Berger J: Clostridium difficile at a community hospital in the Bronx, New York: incidence prevalence and risk factors from 2006 to 2008. Am J Infect Control 2011; 39: 183-7.
18. Louie TJ, Miller MA, Mullane KM, et al: Fidaxomicin versus vancomycin for Clostridium difficile infection. New Eng J Med 2011; 364: 422-31.